JADPRO 2023 CRC

Cecilia BrownConferences | November 15, 2023
There are several key considerations when broaching the subject with patients, speakers said at JADPRO Live 2023.
View More
Cecilia BrownConferences | November 15, 2023
Mary B. Morgan, MSN, ANP-BC, AOCN, discusses the real-world uses of circulating tumor DNA in colorectal cancer.
Cecilia BrownConferences | November 15, 2023
Speakers from a JADPRO Live session on CRC explain how to tailor therapy for patients.
Tammy Triglianos, DNP, ANP-BC, AOCNPGI Cancer | November 13, 2023
A session at JAPDRO Live 2023, the Annual APSHO Meeting, outlined what providers must know about treating this population.
Tammy Triglianos, DNP, ANP-BC, AOCNPConferences | November 13, 2023
There are several ways to overcome barriers surrounding screening for CRC, speakers said at a JADPRO Live session on CRC.
Cecilia BrownConferences | November 10, 2023
Researchers assessed if APP-led education could improve the use of tumor markers for CRC and other cancers.
Cancer Nursing Today EditorsConferences | November 8, 2023
At treatment discontinuation, 91% of patients in the FTD/TPI cohort remained at an ECOG performance status of 0 or 1.
Cancer Nursing Today EditorsGI Cancer | November 8, 2023
Authors of the FRESCO-2 clinical trial reported on treatment-emergent AEs of special interest.
Cecilia BrownConferences | November 8, 2023
A sexual survivorship program is a “feasible” way to manage the sexual effects of pelvic radiotherapy for rectal cancer.
Advertisement
Advertisement